{"name":"Durata Therapeutics","permalink":"durata-therapeutics","crunchbase_url":"http://www.crunchbase.com/company/durata-therapeutics","homepage_url":"http://www.duratatherapeutics.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@duratatherapeutics.com","phone_number":"(646) 871-6480","description":"","created_at":"Wed Dec 23 06:01:11 UTC 2009","updated_at":"Tue Jul 10 22:47:00 UTC 2012","overview":"<p>Durata was created by a five-member venture capital syndicate to pursue late-stage clinical development of novel antibiotic programs. The acquisition was funded through a stock purchase by New Leaf Venture Partners, LLC, Domain Associates, LLC, Aisling Capital, Sofinnova Ventures Inc. and Canaan Partners.</p>\n\n<p>Durata is focused on Vicuronâ€™s antibiotic drug candidate, dalbavancin. Its product portfolio also includes two preclinical antibiotic programs while Pfizer will retain the marketed anti-fungal agent, EraxisTM, which was formerly owned by Vicuron.</p>","image":{"available_sizes":[[[147,102],"assets/images/resized/0010/6506/106506v1-max-150x150.png"],[[147,102],"assets/images/resized/0010/6506/106506v1-max-250x250.png"],[[147,102],"assets/images/resized/0010/6506/106506v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Paul","last_name":"R Edick","permalink":"paul-r-edick","image":null}},{"is_past":false,"title":"CMO","person":{"first_name":"Michael","last_name":"Dunne","permalink":"michael-dunne","image":null}},{"is_past":false,"title":"COO","person":{"first_name":"Corey","last_name":"N. Fishman","permalink":"corey-n-fishman","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":null,"acquisitions":[{"price_amount":null,"price_currency_code":"USD","term_code":null,"source_url":"http://www.finsmes.com/2009/12/newly-formed-durata-therapeutics.html","source_description":"Newly Formed Durata Therapeutics Acquires Vicuron Pharmaceuticals from Pfizer","acquired_year":2009,"acquired_month":12,"acquired_day":21,"company":{"name":"Vicuron Pharmaceuticals","permalink":"vicuron-pharmaceuticals","image":null}}],"offices":[{"description":"","address1":"89 Headquarters Plaza North","address2":"Suite 306 ","zip_code":"07960 ","city":"Morristown","state_code":"NJ","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":"Durata Therapeutics Files For IPO (DRTX)","stoned_year":2012,"stoned_month":3,"stoned_day":22,"source_url":"http://www.businesswire.com/news/home/20120322006678/en/Durata-Therapeutics-Files-Registration-Statement-Proposed-Initial","source_text":null,"source_description":"Business Wire","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Durata Therapeutics","permalink":"durata-therapeutics"}}],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}